Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTENSIUM cream for pain relief in knee osteoarthritis
2026-527647-18-00Phase 4Authorised
- Sponsor
- Boiron
- Start
- Oct 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in knee osteoarthritis (OA) comparing ARTENSIUM cream with Placebo cream (2 arms). Primary endpoint: Change in KOOS Pain subscale score at Day 14. Planned start Oct 2026; status: authorised.
02
Drugs
Artensium
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2026-527647-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-527647-18-00.